Peter D. Noymer
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Peter D. Noymer
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Major | 14 | |
| Extinct | Pharmaceuticals: Major | 5 | |
SteadyMed Therapeutics, Inc.
 SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA.
4
| Holding Company | Medical/Nursing Services | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter D. Noymer
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BIO-RAD LABORATORIES, INC. | Medical Specialties | Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
Transport Corporation of America, Inc.
 Transport Corporation of America, Inc. TruckingTransportation Transport Corporation of America, Inc. provides a wide range of truckload carriage and logistics services. It provides satellite-based communications with the fleet. The company was founded in 1984 and is headquartered in Eagan, MS. | Trucking | Director/Board Member | |
| GERON CORPORATION | Biotechnology | Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Corporate Officer/Principal | |
| HUMANIGEN, INC. | Biotechnology | Director/Board Member | |
| BIONOVO INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| VOLCANO CORPORATION | Medical Specialties | Director of Finance/CFO | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Founder Founder Chief Executive Officer Director of Finance/CFO | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ASANTE SOLUTIONS INC | Medical Specialties | Chairman Director of Finance/CFO | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Aerami Therapeutics Holdings, Inc.
 Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Dance Biopharm Holdings, Inc. engages in providing health care services. The company was founded by John Stuart Patton in 2010 and is headquartered in San Francisco, CA. | Medical Specialties | Director/Board Member | |
Chondrial Therapeutics, Inc.
 Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Pharmaceuticals: Major | Director/Board Member | |
| University of Virginia | College/University | Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree | |
| AMPHASTAR PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Covance Biotechnology Services, Inc.
 Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Graduate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree | |
| State University of New York at Albany | College/University | Undergraduate Degree | |
| State University of New York at Buffalo | College/University | Masters Business Admin | |
| University of California, Davis | College/University | Masters Business Admin | |
| Washington State University | College/University | Doctorate Degree | |
GlycoFi, Inc.
 GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member | |
Guava Technologies, Inc.
 Guava Technologies, Inc. BiotechnologyHealth Technology Guava Technologies, Inc. develops, manufactures and commercializes cytometry systems for cellular analyses. Its products include Guava Personal Cell Analysis systems, Guava PCA, Guava PCA-96, and Guava EasyCyte systems. The company was founded by Goix J. Philippe in 1998 and is headquartered in Hayward, CA. | Biotechnology | Director of Finance/CFO | |
The New York City Investment Fund Manager, Inc.
 The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States. | Investment Managers | Consultant / Advisor | |
| AMARANTUS BIOSCIENCE HOLDINGS, INC. | Biotechnology | Chief Executive Officer | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
ReForm Biologics LLC
 ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| SENESTECH, INC. | Chemicals: Agricultural | Director of Finance/CFO | |
Deerfield Management Co. LP (Private Equity)
 Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Investment Managers | Private Equity Investor | |
| ABSCI CORPORATION | Biotechnology | Director/Board Member | |
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Vescor LLC
 Vescor LLC Pharmaceuticals: MajorHealth Technology Vescor LLC, engages in the discovery and development autophagy targeted therapeutics for cancer treatment. The firm develops small molecule inhibitors of a number of protein targets at critical nodes of the autophagy cascade, perform investigational new drug (IND) enabling studies, and move these into clinical development. The company was founded by Eileen White and Alec Kimmelman and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Bridge Medicines LLC
 Bridge Medicines LLC Pharmaceuticals: MajorHealth Technology Bridge Medicines LLC operates as a drug discovery company. It provides spanning therapeutic areas including infectious disease, oncology, neuropsychiatry, and rare diseases. The company was founded on November 1, 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Tspan LLC
 Tspan LLC Pharmaceuticals: MajorHealth Technology Tspan LLC is an American pharmaceutical manufacturing company. The private company is based in New York. | Pharmaceuticals: Major | Director/Board Member | |
Appello Pharmaceuticals, Inc.
 Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Biotechnology | Director/Board Member | |
Chondrial Therapeutics Holdings LLC
 Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Chondrial Therapeutics Holdings LLC engages in operation of a biotechnology firm. The company was founded in 2016 and is headquartered in Bala Cynwyd, PA. | Miscellaneous Commercial Services | Director/Board Member | |
Itero Holdings LLC
 Itero Holdings LLC Financial ConglomeratesFinance Itero Holdings LLC provides investment services. The private company is based in San Jose, CA. | Financial Conglomerates | Chief Executive Officer | |
Itero Biopharmaceuticals LLC
 Itero Biopharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Itero Biopharmaceuticals LLC provides royalty payment services for licensing agreements. The American company was founded by V. Bryan Lawlis. | Miscellaneous Commercial Services | Chief Executive Officer | |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Pharmaceuticals: Major | Director/Board Member | |
| COMERA LIFE SCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 47 |
| Frankreich | 2 |
| Schweden | 2 |
| China | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 33 |
| Consumer Services | 9 |
| Finance | 5 |
| Communications | 3 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 80 |
| Director of Finance/CFO | 35 |
| Corporate Officer/Principal | 32 |
| President | 24 |
| Chief Executive Officer | 22 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Bobba Venkatadri | 24 |
| V. Lawlis | 21 |
| Stephen Farr | 16 |
| Donald Huffman | 16 |
| Jonathan Rigby | 16 |
| David Nassif | 13 |
| Elizabeth Cermak | 13 |
| Michael Molkentin | 12 |
| William Slattery | 12 |
| Daniel P. Maher | 11 |
| Richard P. Thompson | 10 |
| Stephen Jaeger | 10 |
| William Hodder | 9 |
| Jeff Myers | 9 |
| Maximillian D. Fiore | 9 |
- Börse
- Insiders
- Peter D. Noymer
- Unternehmensverbindungen
